August 18, 2011 -- Wetzlar, Germany / Hørsholm, Denmark. Leica Microsystems, world-leading providers of Total Digital Pathology solutions, and Visiopharm the leading provider of Histoinformatics Solutions for Life-Sciences, today announce the completed integration of Leica’s SlidePath Digital Image Hub with Visiopharm’s Whole-Slide InformaticsTM solutions for Digital Pathology. Users can now take advantage of superior image capture and management from Leica Microsystems and excellent Whole Slide image analysis and Whole Slide Stereology from Visiopharm in a single system.
This integration provides a truly streamlined workflow for customers using image analysis and stereology in digital pathology. All images stored on the Digital Image Hub server can be browsed and accessed via the Visiopharm software. Selected images are then easily opened and analyzed by either Visiopharm’s image analysis software or stereology software. Following analysis, users can quickly view the resulting data and associated slides through the Visiopharm software interface.
Leica’s Digital Image Hub, developed by SlidePath, is a scalable enterprise-level solution for the management and archiving of digital slides and associated data. As Digital Image Hub is accessed via a standard internet browser and supports images from a variety of digital slide scanners, it is the perfect partner for Visiopharm’s whole slide analysis solutions.
Stavanger University Hospital have chosen Leica Microsystems’ Total Digital Pathology solution for scanning and storage of digital slides, and the Visiopharm solution for image analysis.
Dr. Kjell H Kjellevold, Head of the Pathology Department says, “For us, the combination of these two systems is ideal. The speed and image quality of the Leica SCN400 slide scanner combined with the Digital Image Hub management solution is exactly what is required for making Digital Pathology feasible for research work. The image analysis software from Visiopharm consolidates simplicity for routine work and the flexibility for research. This, together with the low costs of learning and computation, was critical for our decision”.
While Leica Microsystems will continue to develop and expand their existing range of Digital Pathology image analysis solutions, including Tissue IA and the Ariol system, the integration with Visiopharm gives additional options to customers, enabling them to choose the analysis solution that is right for their needs.
Visiopharm will continue to consolidate and expand its integration to the leading slide databases on the Digital Pathology market.
Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.
Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.
Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.
The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.
Visiopharm provides advanced analysis software for digital pathology.
The Whole Slide Informatics™ platform from Visiopharm® combines image analysis and stereology on the same software platform, making it possible to obtain valid and unbiased quantitative data both in the 2- and 3- dimensional space by analysis of planar tissue sections.
The image analysis tools VisiomorphDP and TissuemorphDP provides solutions for both clinical and pre-clinical research applications with flexibility, robustness, and low computational costs even for complex analysis. With a novel approach to setting up image analysis protocols, typical image analysis problems such as quantifying nuclear, membrane, and cytoplasmic markers, can be addressed effectively with just a few hours of training.
Visiopharm’s patented Whole Slide Stereology solutions automates time-consuming parts of the classical stereology methods helping the researcher to perform stereological analysis significantly faster and more efficient than with classical stereology.
Our software solutions are designed to operate on all major scanner brands on the market and a wide variety of classical microscopes.
Visiopharm is a privately owned company. The headquarters is located in Medicon Valley, Denmark, one of the strongest bio-regions in Europe. For more information please visit: www.visiopharm.com